POS0478 SURVIVALTO b/tsDMARDs IN PATIENTS AFTER FULFILLING DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS CLASSIFICATION

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1OP0137 CHALLENGING THE DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: COMPARATIVE ANALYSIS OF CLINICAL EFFICACY AND DRUG RETENTION OF SUBSEQUENT BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2024
2. 2P116 First-line tumour necrosis factor inhibitor induction in early rheumatoid arthritis is associated with a reduction in future difficult-to-treat disease2026
3. 3AB1558-HPR UNRAVELING THE COMPLEXITY: A DESCRIPTION OF “DIFFICULT TO TREAT” IN A COLOMBIAN COHORT OF RHEUMATOID ARTHRITIS PATIENTS2024
4. 4OP0131 OCCURRENCE AND PREDICTORS OF MULTIPLE DMARD TREATMENT FAILURE IN RHEUMATID ARTHRITIS (RA): RESULTS FROM THE SWEDISH RHEUMATOLOGY QUALITY REGISTER2024
5. 5AB0547 PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS HAVE HIGHER LEVELS OF INFLAMMATION ON ULTRASOUND2024